| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 02/20/2013 | CN102935201A Chinese herbal preparation for treating hyperostosis, lumbar muscle degeneration, pain from rheumatism and the like |
| 02/20/2013 | CN102935185A Pills for treating neurasthenia and preparation method |
| 02/20/2013 | CN102935179A Chinese medicament for treating rheumatic arthritis |
| 02/20/2013 | CN102935135A Traditional Chinese medicine composition for soft tissue injury treatment |
| 02/20/2013 | CN102935134A Cooling paste for child and preparation method thereof |
| 02/20/2013 | CN102935133A Traditional Chinese medicine composition for treating rheumatic arthritis as well as preparation method and application thereof |
| 02/20/2013 | CN102935125A Externally applied Chinese herbal composition with facial redness removing effect, preparation and method for preparing externally applied Chinese herbal composition with facial redness removing effect |
| 02/20/2013 | CN102935089A Application of dog whelk in antipyretic anti-inflammatory drug preparation |
| 02/20/2013 | CN102935078A Ibuprofen oral dispersing film agent |
| 02/20/2013 | CN102935042A Mask powder and manufacture method thereof |
| 02/20/2013 | CN102935039A Traditional Chinese medicine eucommia bark toothpaste and preparation method thereof |
| 02/20/2013 | CN102358880B Formula and production method of health care vinegar capable of treating rheumatism |
| 02/20/2013 | CN102344892B Chinese isolate of Leachiii mycoplasma, isolation culture medium and purpose thereof |
| 02/20/2013 | CN102302583B Medicinal composition for reducing swelling and alleviating pain |
| 02/20/2013 | CN102294031B Pharmaceutical formulation comprising proton pump inhibitor, NSAID and antacids |
| 02/20/2013 | CN102225097B Application of extract of Rheum emodi Wall. in preparing anti-fibrosis drug |
| 02/20/2013 | CN102210736B Medicine composition for treating tenosynovitis and preparation method thereof |
| 02/20/2013 | CN102205056B Medicinal liquor for treating senile lumbocrural arthralgia |
| 02/20/2013 | CN101678077B Novel antiphlogistic-analgesic agent |
| 02/20/2013 | CN101129418B Compound formulation containing collybia albuminosa and green mushroom bacterium |
| 02/19/2013 | USRE44017 N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use |
| 02/19/2013 | US8378099 Boronic ester and acid compounds, synthesis and uses |
| 02/19/2013 | US8377968 N-piperidinyl acetamide derivatives as calcium channel blockers |
| 02/19/2013 | US8377946 Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors |
| 02/19/2013 | US8377936 Nicotinic receptor agonists for the treatment of inflammatory diseases |
| 02/19/2013 | US8377897 Compositions and methods for non-parenteral delivery of oligonucleotides |
| 02/19/2013 | US8377690 Cells and methods for producing blocking antibodies to human RANKL |
| 02/19/2013 | US8377679 Use of probiotic lactic acid bacteria for balancing the skin's immune system |
| 02/19/2013 | US8377483 Bioactivation of iron salt, especially an ferric ferrous salt, by adding a magnesium salt (MgCl2); useful as a medicine to treat diseases such as diabetes, freshness preservative agent, and animal and plant growth promoter |
| 02/19/2013 | CA2573371C Pyrimidines as plk inhibitors |
| 02/19/2013 | CA2557054C (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor |
| 02/19/2013 | CA2486187C Kinase inhibitors |
| 02/19/2013 | CA2442964C Improved anti-inflammatory herbal composition and method of use |
| 02/14/2013 | WO2013022996A2 The utility of nematode small molecules |
| 02/14/2013 | WO2013022829A2 Endomucin as an anti-inflammatory agent |
| 02/14/2013 | WO2013022243A2 Novel biphenyl derivative or a pharmaceutically acceptable salt thereof, and pharmaceutical composition for preventing or treating inflammatory diseases or autoimmune diseases comprising same as an active ingredient |
| 02/14/2013 | WO2013022091A1 Therapeutic agent for autoimmune diseases comprising pd-1 agonist |
| 02/14/2013 | WO2013021891A1 Amino-acid-containing composition for enhancing recovery from muscle fatigue |
| 02/14/2013 | WO2013021021A1 Novel soft pde4 inhibitors |
| 02/14/2013 | WO2013020622A1 N-(benzimimdazol-2-yl)-cyclopropane carboxamides as lysophosphatidic acid antagonists |
| 02/14/2013 | WO2013020302A1 Diclofenac sodium sustained release tablet and preparation process therefor |
| 02/14/2013 | WO2012128501A9 Pharmaceutical composition containing, as an active ingredient, m-3m3fbs, which is an activator of phospholipase c, for preventing or treating inflammatory diseases or infectious diseases |
| 02/14/2013 | US20130041028 Methods of using (1s,3s)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid |
| 02/14/2013 | US20130041026 Anhydrous and hemihydrate crystalline forms of an (r)-baclofen prodrug, methods of synthesis and methods of use |
| 02/14/2013 | US20130041024 Methods for the Diagnosis, Control and Prophylaxis of Inflammation and Mitigation of Inflammatory Conditions in Canines |
| 02/14/2013 | US20130041020 Methods of Control and Prophylaxis of Inflammation and Mitigation of Inflammatory Conditions in Companion Animals |
| 02/14/2013 | US20130041019 SDF-1 Binding Nucleic Acids |
| 02/14/2013 | US20130041008 Compounds for enzyme inhibition |
| 02/14/2013 | US20130041007 Selective Androgen Receptor Modulators |
| 02/14/2013 | US20130041006 Pharmaceutical composition for intracellar acidification with cis-urocanic acid |
| 02/14/2013 | US20130041005 Pharmaceutical compositions comprising neuropilin inhibitors, and their use for the prevention and/or treatment of angiogenic disorders and cancers |
| 02/14/2013 | US20130041002 Denibulin di-hydrochloride |
| 02/14/2013 | US20130041000 Novel azole compound |
| 02/14/2013 | US20130040997 Novel pyridine carboxylic acid based compound used as a p2x1 and p2x3 receptor antagonist, a production method for the same and a composition comprising the same |
| 02/14/2013 | US20130040996 Composition for treating atherosclerosis and a preparation method thereof |
| 02/14/2013 | US20130040982 Oral sustained release formulation of huperzine a |
| 02/14/2013 | US20130040981 Pyridylvinylpyrazoloquinolines as PAR1 inhibitors |
| 02/14/2013 | US20130040980 Cci-779 concentrate formulations |
| 02/14/2013 | US20130040974 Piperidine inhibitors of janus kinase 3 |
| 02/14/2013 | US20130040964 1,2,3-triazole-based peptidomimetic integrin inhibitors for the diagnosis and therapy of tumors |
| 02/14/2013 | US20130040962 P38 MAP Kinase Inhibitors |
| 02/14/2013 | US20130040944 Mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| 02/14/2013 | US20130040943 Tricyclic pyridyl-vinyl pyrroles as par1 inhibitors |
| 02/14/2013 | US20130040940 Mercaptoamidine derivatives and methods of use |
| 02/14/2013 | US20130040939 Oral Suspension Formulations of Esclicarbazepine Acetate |
| 02/14/2013 | US20130040932 Substituted aryl sulfone derivatives as calcium channel blockers |
| 02/14/2013 | US20130040930 Novel amide derivative and use thereof as medicine |
| 02/14/2013 | US20130040928 Nitrogen heterocycle derivatives, preparation thereof and application thereof in human therapeutics |
| 02/14/2013 | US20130040926 Novel compound |
| 02/14/2013 | US20130040920 Composition containing resveratrol and/or derivatives thereof and plant oil, process for producing said composition, nutraceutical and/or pharmaceutical product, and method for enhancing the potential of resveratrol |
| 02/14/2013 | US20130040919 C-nitroso-derived nitroxyl donors |
| 02/14/2013 | US20130040916 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses |
| 02/14/2013 | US20130040905 Combination Of Drugs With Protein-Binding Prodrugs |
| 02/14/2013 | US20130040902 Method for enhancing milk quantity and quality |
| 02/14/2013 | US20130040900 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 02/14/2013 | US20130040892 Iap bir domain binding compounds |
| 02/14/2013 | US20130039983 Process for the production of ralfinamide salts substantially free from impurities having genotoxic effects |
| 02/14/2013 | US20130039981 Quick Dissolving, Long Acting Zinc Therapeutic Formulations |
| 02/14/2013 | US20130039979 Medication on the basis of 3,3'-diindolylmethane (dim) with high-bioavailability and its use in treatment of human hyperplastic and inflammatory diseases |
| 02/14/2013 | US20130039976 Sodium channel blocker for treatment of loss of superficial sensitivity |
| 02/14/2013 | US20130039971 Compositions and methods for inhibition of vegf |
| 02/14/2013 | US20130039970 Processes and Compositions for Liposomal and Efficient Delivery of Gene Silencing Therapeutics |
| 02/14/2013 | US20130039960 Compositions for reduction of side effects |
| 02/14/2013 | US20130039956 Use of nitrocarboxylic acids for the treatment, diagnosis and prophylaxis of aggressive healing patterns |
| 02/14/2013 | US20130039949 Immunomodulating compounds and related compositions and methods |
| 02/14/2013 | US20130039928 Compositions and methods for reversing corticosteroid resistance or treating respiratory infections |
| 02/14/2013 | US20130039925 Alternative pathway specific antibodies for treating arthritis |
| 02/14/2013 | US20130039924 Adult stem cells/progenitor cells and stem cell proteins for treatment of eye injuries and diseases |
| 02/14/2013 | US20130039923 Anti-human interleukin-20 antibodies |
| 02/14/2013 | US20130039919 Novel plasminogen receptor, polypeptides and antibodies thereof |
| 02/14/2013 | US20130039918 Pharmaceutical Composition Using Connective-tissue Growth Factor |
| 02/14/2013 | US20130039916 ENGINEERED ANTI-IL-23p19 ANTIBODIES |
| 02/14/2013 | US20130039906 PYRAZOLO[3,4-c]PYRIDINE COMPOUNDS AND METHODS OF USE |
| 02/14/2013 | US20130039902 Non-neurotoxic plasminogen activating factors for treating of stroke |
| 02/14/2013 | US20130039892 Adherent stromal cells derived from plancentas of multiple donors and uses thereof |
| 02/14/2013 | US20130039885 Leukotoxin e/d as a new anti-inflammatory agent and microbicide |
| 02/14/2013 | US20130039880 Cyclodextrin-based polymers for therapeutics delivery |
| 02/14/2013 | US20130039851 Stabilizing Alkylglycoside Compositions and Methods Thereof |
| 02/14/2013 | US20130039850 Heterologous antibodies which bind human cd4 |
| 02/14/2013 | US20130039848 Fluorescent silica-based nanoparticles |